Literature DB >> 8351958

Effects of chronic heroin abuse on bone and mineral metabolism.

M Pedrazzoni1, P P Vescovi, L Maninetti, M Michelini, G Zaniboni, G Pioli, D Costi, F S Alfano, M Passeri.   

Abstract

Though the chronic use of opiates can modify several body functions, only a few data are available on the effects of opioid drugs on mineral metabolism. We have examined the possible consequences of chronic opiate abuse on bone mass, bone turnover and calcium metabolism in 13 male chronic heroin users, examined 1-2 days after the last administration of the drug (group A), 14 former male heroin addicts, examined 4-24 months after drug discontinuation (group B), and 22 healthy, age- and sex-matched control subjects. In group A, the vertebral bone mineral density (measured by Dual-Photon Absorptiometry) was significantly lower (p < 0.05) than in the control subjects, despite similar values of total body bone mineral, lean body and fat mass. Blood-ionised calcium and urinary calcium and hydroxyproline were significantly increased (p < 0.01), whereas parathyroid hormone was lower than in controls (p < 0.01). Bone alkaline phosphatase and osteocalcin, however, were not significantly different from the control values. LH and testosterone levels were low (p < 0.01 vs controls). In contrast, group B subjects did not show significant differences from the control group. The chronic abuse of opioid drugs may be associated with altered bone metabolism and reduced trabecular bone mass, attributable, at least in part, to gonadal deficiency. These alterations seem reversible after drug discontinuation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8351958     DOI: 10.1530/acta.0.1290042

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  17 in total

Review 1.  Care of the human immunodeficiency virus-infected menopausal woman.

Authors:  Helen Elizabeth Cejtin
Journal:  Am J Obstet Gynecol       Date:  2011-12-30       Impact factor: 8.661

2.  Prospective evaluation of bone mineral density among middle-aged HIV-infected and uninfected women: Association between methadone use and bone loss.

Authors:  Anjali Sharma; Hillel W Cohen; Ruth Freeman; Nanette Santoro; Ellie E Schoenbaum
Journal:  Maturitas       Date:  2011-09-25       Impact factor: 4.342

3.  Prospective study of bone mineral density changes in aging men with or at risk for HIV infection.

Authors:  Anjali Sharma; Peter L Flom; Jeremy Weedon; Robert S Klein
Journal:  AIDS       Date:  2010-09-24       Impact factor: 4.177

4.  Low vitamin d status of patients in methadone maintenance treatment.

Authors:  Theresa W Kim; Daniel P Alford; Michael F Holick; Alan O Malabanan; Jeffrey H Samet
Journal:  J Addict Med       Date:  2009-09       Impact factor: 3.702

5.  Skeletal turnover, bone mineral density, and fractures in male chronic abusers of alcohol.

Authors:  C Santori; M Ceccanti; D Diacinti; M L Attilia; L Toppo; E D'Erasmo; E Romagnoli; M L Mascia; C Cipriani; A Prastaro; V Carnevale; S Minisola
Journal:  J Endocrinol Invest       Date:  2008-04       Impact factor: 4.256

6.  Is opium addiction a risk factor for bone loss?

Authors:  M H Gozashti; A Shahesmaeili; N Amini Zadeh
Journal:  Iran Red Crescent Med J       Date:  2011-07-01       Impact factor: 0.611

7.  Effect of tramadol at different doses on orthodontic tooth movement and bone resorption in rats.

Authors:  Hossein Aghili; Mahdjoube Goldani Moghadam; Soghra Yassaei; Amir Reza Fattahi Meybodi; Seyed Mohamad Ali Tabatabaei
Journal:  Dent Res J (Isfahan)       Date:  2013-05

8.  Effect of Tramadol (μ-opioid receptor agonist) on orthodontic tooth movements in a rat model.

Authors:  M Rashidpour; M S Ahmad Akhoundi; T Hosseinzadeh Nik; Ar Dehpour; M Alaeddini; E Javadi; H Noroozi
Journal:  J Dent (Tehran)       Date:  2012-06-30

9.  Bone mineral density in human immunodeficiency virus-1 infected men with hypogonadism prior to highly-active-antiretroviral-therapy (HAART).

Authors:  J Teichmann; U Lange; T Discher; J Lohmeyer; H Stracke; R G Bretzel
Journal:  Eur J Med Res       Date:  2009       Impact factor: 2.175

10.  A review on hematological factors in opioid-dependent people (opium and heroin) after the withdrawal period.

Authors:  Tahereh Haghpanah; Mohammadreza Afarinesh; Kouros Divsalar
Journal:  Addict Health       Date:  2010 Winter-Spring
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.